Growth and growth biomarker changes after adenotonsillectomy

Systematic review and metaanalysis

Karen A. Bonuck, K. Freeman, J. Henderson

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Objective: To determine the effect of adenoidectomy and/or tonsillectomy ("adenotonsillectomy") upon growth and growth biomarkers, in the context of sleep disordered breathing (SDB). SDB in children, primarily due to adenotonsillar hypertrophy, increases the risk of growth failure. Design: Systematic review and meta-analysis. PubMed, ERIC and Cochrane Reviews databases from January 1980 to November 2007 were searched for studies reporting: pre/post-adenotonsillectomy height and weight changes as percentage increased or decreased, raw data, z scores or centiles, or: IGF-1 and/or IGFBP-3 serum-level changes as z scores or raw data. For anthropometrics, the meta-analysis included studies presenting z scores or centiles. Setting: Observational studies. Patients: Otherwise healthy children, not selected for obesity. Main outcome measures: Pre/post-surgery changes in standardised height and weight, and IGF-1 and IGFBP-3. Results: Of 211 citations identified, 20 met systematic review criteria. SDB was an enrolment criterion in 13 of the studies, and one of several enrolment criteria in three. Meta-analysis findings for pre/post-surgery changes were: standardised height: 10 studies, 363 total children, pooled standardised mean differences (SMD) = 0.34 (95% CI 0.20 to 0.47); standardised weight: 11 studies, 390 total children, pooled SMD = 0.57 (95% CI 0.44 to 0.70); IGF-1: 7 studies, 177 total children, pooled SMD = 0.53 (95% CI 0.33 to 0.73); IGFBP-3: 7 studies, 177 total children, pooled SMD = 0.59 (95% CI 0.34 to 0.83). Conclusions: Standardised height and weight, and IGF-1 and IGFBP-3 increased significantly after adenotonsillect- omy. Findings suggest that primary care providers and specialists consider SDB secondary to adenotonsillar hypertrophy when screening, treating and referring children with growth failure.

Original languageEnglish (US)
Pages (from-to)83-91
Number of pages9
JournalArchives of Disease in Childhood
Volume94
Issue number2
DOIs
StatePublished - Feb 2009

Fingerprint

Biomarkers
Insulin-Like Growth Factor Binding Protein 3
Sleep Apnea Syndromes
Insulin-Like Growth Factor I
Growth
Meta-Analysis
Weights and Measures
Hypertrophy
Adenoidectomy
Tonsillectomy
PubMed
Observational Studies
Primary Health Care
Obesity
Outcome Assessment (Health Care)
Databases
Serum

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Growth and growth biomarker changes after adenotonsillectomy : Systematic review and metaanalysis. / Bonuck, Karen A.; Freeman, K.; Henderson, J.

In: Archives of Disease in Childhood, Vol. 94, No. 2, 02.2009, p. 83-91.

Research output: Contribution to journalArticle

@article{7fbb1afd51dc41d8b2b5dbcd3410b2a3,
title = "Growth and growth biomarker changes after adenotonsillectomy: Systematic review and metaanalysis",
abstract = "Objective: To determine the effect of adenoidectomy and/or tonsillectomy ({"}adenotonsillectomy{"}) upon growth and growth biomarkers, in the context of sleep disordered breathing (SDB). SDB in children, primarily due to adenotonsillar hypertrophy, increases the risk of growth failure. Design: Systematic review and meta-analysis. PubMed, ERIC and Cochrane Reviews databases from January 1980 to November 2007 were searched for studies reporting: pre/post-adenotonsillectomy height and weight changes as percentage increased or decreased, raw data, z scores or centiles, or: IGF-1 and/or IGFBP-3 serum-level changes as z scores or raw data. For anthropometrics, the meta-analysis included studies presenting z scores or centiles. Setting: Observational studies. Patients: Otherwise healthy children, not selected for obesity. Main outcome measures: Pre/post-surgery changes in standardised height and weight, and IGF-1 and IGFBP-3. Results: Of 211 citations identified, 20 met systematic review criteria. SDB was an enrolment criterion in 13 of the studies, and one of several enrolment criteria in three. Meta-analysis findings for pre/post-surgery changes were: standardised height: 10 studies, 363 total children, pooled standardised mean differences (SMD) = 0.34 (95{\%} CI 0.20 to 0.47); standardised weight: 11 studies, 390 total children, pooled SMD = 0.57 (95{\%} CI 0.44 to 0.70); IGF-1: 7 studies, 177 total children, pooled SMD = 0.53 (95{\%} CI 0.33 to 0.73); IGFBP-3: 7 studies, 177 total children, pooled SMD = 0.59 (95{\%} CI 0.34 to 0.83). Conclusions: Standardised height and weight, and IGF-1 and IGFBP-3 increased significantly after adenotonsillect- omy. Findings suggest that primary care providers and specialists consider SDB secondary to adenotonsillar hypertrophy when screening, treating and referring children with growth failure.",
author = "Bonuck, {Karen A.} and K. Freeman and J. Henderson",
year = "2009",
month = "2",
doi = "10.1136/adc.2008.141192",
language = "English (US)",
volume = "94",
pages = "83--91",
journal = "Archives of Disease in Childhood",
issn = "0003-9888",
publisher = "BMJ Publishing Group",
number = "2",

}

TY - JOUR

T1 - Growth and growth biomarker changes after adenotonsillectomy

T2 - Systematic review and metaanalysis

AU - Bonuck, Karen A.

AU - Freeman, K.

AU - Henderson, J.

PY - 2009/2

Y1 - 2009/2

N2 - Objective: To determine the effect of adenoidectomy and/or tonsillectomy ("adenotonsillectomy") upon growth and growth biomarkers, in the context of sleep disordered breathing (SDB). SDB in children, primarily due to adenotonsillar hypertrophy, increases the risk of growth failure. Design: Systematic review and meta-analysis. PubMed, ERIC and Cochrane Reviews databases from January 1980 to November 2007 were searched for studies reporting: pre/post-adenotonsillectomy height and weight changes as percentage increased or decreased, raw data, z scores or centiles, or: IGF-1 and/or IGFBP-3 serum-level changes as z scores or raw data. For anthropometrics, the meta-analysis included studies presenting z scores or centiles. Setting: Observational studies. Patients: Otherwise healthy children, not selected for obesity. Main outcome measures: Pre/post-surgery changes in standardised height and weight, and IGF-1 and IGFBP-3. Results: Of 211 citations identified, 20 met systematic review criteria. SDB was an enrolment criterion in 13 of the studies, and one of several enrolment criteria in three. Meta-analysis findings for pre/post-surgery changes were: standardised height: 10 studies, 363 total children, pooled standardised mean differences (SMD) = 0.34 (95% CI 0.20 to 0.47); standardised weight: 11 studies, 390 total children, pooled SMD = 0.57 (95% CI 0.44 to 0.70); IGF-1: 7 studies, 177 total children, pooled SMD = 0.53 (95% CI 0.33 to 0.73); IGFBP-3: 7 studies, 177 total children, pooled SMD = 0.59 (95% CI 0.34 to 0.83). Conclusions: Standardised height and weight, and IGF-1 and IGFBP-3 increased significantly after adenotonsillect- omy. Findings suggest that primary care providers and specialists consider SDB secondary to adenotonsillar hypertrophy when screening, treating and referring children with growth failure.

AB - Objective: To determine the effect of adenoidectomy and/or tonsillectomy ("adenotonsillectomy") upon growth and growth biomarkers, in the context of sleep disordered breathing (SDB). SDB in children, primarily due to adenotonsillar hypertrophy, increases the risk of growth failure. Design: Systematic review and meta-analysis. PubMed, ERIC and Cochrane Reviews databases from January 1980 to November 2007 were searched for studies reporting: pre/post-adenotonsillectomy height and weight changes as percentage increased or decreased, raw data, z scores or centiles, or: IGF-1 and/or IGFBP-3 serum-level changes as z scores or raw data. For anthropometrics, the meta-analysis included studies presenting z scores or centiles. Setting: Observational studies. Patients: Otherwise healthy children, not selected for obesity. Main outcome measures: Pre/post-surgery changes in standardised height and weight, and IGF-1 and IGFBP-3. Results: Of 211 citations identified, 20 met systematic review criteria. SDB was an enrolment criterion in 13 of the studies, and one of several enrolment criteria in three. Meta-analysis findings for pre/post-surgery changes were: standardised height: 10 studies, 363 total children, pooled standardised mean differences (SMD) = 0.34 (95% CI 0.20 to 0.47); standardised weight: 11 studies, 390 total children, pooled SMD = 0.57 (95% CI 0.44 to 0.70); IGF-1: 7 studies, 177 total children, pooled SMD = 0.53 (95% CI 0.33 to 0.73); IGFBP-3: 7 studies, 177 total children, pooled SMD = 0.59 (95% CI 0.34 to 0.83). Conclusions: Standardised height and weight, and IGF-1 and IGFBP-3 increased significantly after adenotonsillect- omy. Findings suggest that primary care providers and specialists consider SDB secondary to adenotonsillar hypertrophy when screening, treating and referring children with growth failure.

UR - http://www.scopus.com/inward/record.url?scp=59649097349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59649097349&partnerID=8YFLogxK

U2 - 10.1136/adc.2008.141192

DO - 10.1136/adc.2008.141192

M3 - Article

VL - 94

SP - 83

EP - 91

JO - Archives of Disease in Childhood

JF - Archives of Disease in Childhood

SN - 0003-9888

IS - 2

ER -